Sarkis Clinical Trials
Lake City, Florida, United States
Medical clinic in Gainesville, Florida
611 NW 60th St C, Gainesville, FL 32607
About Sarkis Clinical Trials
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Tonix Pharmaceuticals, Inc.
2
Indivior Inc.
1
Janssen Research & Development, LLC
1
Pfizer
1
Shire
1
Clinical Trials at Sarkis Clinical Trials
During the past decade, Sarkis Clinical Trials conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 4 clinical trials were completed, i.e. on
average, 133.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder
2012-04-03
2014-05-22
Completed
549
Safety and Efficacy Study of TNX-102 SL in Subjects With Military-Related PTSD and Related Conditions
2014-10-01
2016-05-01
Completed
247
POC Study in Partially Responsive Generalized Anxiety Disorder
2014-11-01
2015-10-01
Terminated
90
Open Label Extension Safety and Efficacy Study of TNX-102 SL Tablets in Military Related PTSD and Related Conditions
2015-04-01
2016-08-01
Completed
159
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
2015-07-27
2017-01-31
Completed
775
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42847922 in Participants With Insomnia Disorder
2017-11-23
2019-04-03
Completed
365
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Sarkis Clinical Trials" #1 sponsor was "Tonix Pharmaceuticals, Inc." with 2 trials, followed by "Indivior Inc." with 1 trials
sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Shire"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Sarkis Clinical Trials
According to Clinical.Site data, the most researched conditions in "Sarkis Clinical Trials" are
"PTSD" (2 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials), "Generalized Anxiety Disorder" (1 trials), "Insomnia Disorders" (1 trials) and "Opioid Use Disorder" (1 trials). Many other conditions were trialed in "Sarkis Clinical Trials" in a lesser frequency.
Clinical Trials Intervention Types at Sarkis Clinical Trials
Most popular intervention types in "Sarkis Clinical Trials" are "Drug" (6 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "TNX-102 SL" (2 trials), "JNJ-42847922, 10 mg" (1 trials), "JNJ-42847922, 20 mg" (1 trials) and "JNJ-42847922, 5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sarkis Clinical Trials
The vast majority of trials in "Sarkis Clinical Trials" are
6 trials for "All" genders.
Clinical Trials Status at Sarkis Clinical Trials
Currently, there are NaN active trials in "Sarkis Clinical Trials".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Sarkis Clinical Trials,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Sarkis Clinical Trials, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".